Daniel Benjamin
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Daniel Benjamin sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Daniel Benjamin: 5 sponsored US clinical trials, none currently recruiting.
Daniel Benjamin sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 2 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Candidiasis, with 1 trials.
Upper-quartile sponsor footprint
Daniel Benjamin sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Immune Modulators for Treating COVID-19
NCT04593940
Pharmacokinetics and Safety of Ertapenem in the Postpartum Period
NCT01587495
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
NCT01431326
Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight
NCT00734539
Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers
NCT00797420
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 3 | 2 |
Therapeutic Areas
How the Daniel Benjamin archive is shaped
5 indexed studies, none listed as recruiting (0% open); 4 completed (80%).
Phase mix: 2 late (III/IV) vs 2 early (I/II) (balanced across stages).
Top condition: Candidiasis (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Daniel Benjamin: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Daniel Benjamin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Daniel Benjamin page
5 registered trials is a research-attention snapshot, not an endorsement of Daniel Benjamin or any single study.
- None of Daniel Benjamin's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Candidiasis is the condition Daniel Benjamin studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Candidiasis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Daniel Benjamin pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.